Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Active not recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 22Pancreatic Neoplasms 16Neoplasm Metastasis 9Rectal Neoplasms 5Neuroblastoma 5Neoplasms 5Colonic Neoplasms 5Stomach Neoplasms 4Sarcoma 4Rhabdomyosarcoma 4Lung Neoplasms 4Sarcoma, Ewing 3Cholangiocarcinoma 3Small Cell Lung Carcinoma 2Ovarian Neoplasms 2Medulloblastoma 2Hepatoblastoma 2Glioma 2Esophageal Squamous Cell Carcinoma 2Esophageal Neoplasms 2Carcinoma, Hepatocellular 2Breast Neoplasms 2Bone Neoplasms 2Adenocarcinoma Of Esophagus 2Uterine Cervical Neoplasms 1Urinary Bladder Neoplasms 1Turcot syndrome 1Solid Cancer 1Rhabdomyosarcoma, Embryonal 1Rhabdomyosarcoma, Alveolar 1

Interventions

pembrolizumab 5Nivolumab 3durvalumab 2atezolizumab 2relatlimab 1fludarabine phosphate 1fludarabine 1denileukin diftitox 1danvatirsen 1avelumab 1Specimen Handling 1Magnetic Resonance Spectroscopy 1Irinotecan 1Immunoglobulin G 1Immune Checkpoint Inhibitors 1IMM-101 1E7777 fusion protein 1Docetaxel 1Disulfides 1Diffusion Tensor Imaging 1Cyclophosphamide 1ALT-803 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Active not recruiting × Turcot syndrome × Irinotecan × Clear all
NCT05838768 2026-03-24

Study of HRO761 Alone or in Combination in Cancer Patients With Specific DNA Alterations Called Microsatellite Instability or Mismatch Repair Deficiency.

Novartis

Phase 1 Active not recruiting
123 enrolled
Gastrointestinal

Turcot syndrome, Neoplasm Metastasis, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡